News classification
News Center
Viwit Pharmaceutical Is Now Officially GMP Certified by South Korean MFDS
- Categories:In 2023
- Author:
- Origin:
- Time of issue:2023-02-27 13:37
(Summary description)Shandong, February 13, 2023 -- Viwit Pharmaceutical, an innovation-driven global company providing CDMO services to pharmaceutical and biotech industries, successfully passed the GMP inspection and approved by the South Korean regulatory agency, the Ministry of Food and Drug Safety (MFDS).
Viwit Pharmaceutical Is Now Officially GMP Certified by South Korean MFDS
(Summary description)Shandong, February 13, 2023 -- Viwit Pharmaceutical, an innovation-driven global company providing CDMO services to pharmaceutical and biotech industries, successfully passed the GMP inspection and approved by the South Korean regulatory agency, the Ministry of Food and Drug Safety (MFDS).
- Categories:In 2023
- Author:
- Origin:
- Time of issue:2023-02-27 13:37
- Views:
Shandong, February 13, 2023 -- Viwit Pharmaceutical, an innovation-driven global company providing CDMO services to pharmaceutical and biotech industries, successfully passed the GMP inspection and approved by the South Korean regulatory agency, the Ministry of Food and Drug Safety (MFDS).
December 5, 2022, MFDS authorities initiated a real-time virtual audit on Viwit’s manufacturing site. Operation facilities, utility systems, warehouses, and quality control labs along with all relevant documentation and SOPs were reviewed. After a strict and intense 5-day auditing procedure, MFDS officials concluded the successful inspection with approval and announced that Viwit is GMP-compliant with high standards. Two active pharmaceutical ingredients (APIs) Mirabegron and Efinaconazole are now approved and registered under the Korean MFDS.
This exciting achievement not only marks another significant milestone in Viwit’s successful regulatory inspection history, but also verifies Viwit’s consistent satisfactory quality, reliability, and competitiveness in the international drug development and manufacturing industry. Moving forward, Viwit aims to continuously demonstrate its excellence in robust pharmaceutical manufacturing and gain more of the marketplace in order to contribute more to the drug development world, as indicated by the company’s vision, “Win social respect and trust. Achieve the goal of being the world's leading pharmaceutical enterprise” – Wei, Yanjun, CEO.
About Viwit Pharmaceuticals
Viwit Pharmaceuticals is a premier clinical and commercial staged CDMO with 17+ year’s expertise in the pharmaceutical industry. The company provides reliable and excellent development and manufacturing services for key starting materials, advanced intermediates, APIs (small molecules and peptides), and finished drug products. Viwit also offers a list of 35+ company-launched drug products in the areas of innovative biopharmaceuticals, characteristic generics, and improved new drugs.
Scan the QR code to read on your phone
VIWIT 沪ICP备12014533号-2 Terms of Use